Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
An Irish government-backed enterprise fund has, for the first time in its 10-year history, named a cannabis company its High Potential Start-up (HPSU) Founder of the Year award.
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy.
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
The Global Cannabis Regulatory Summit (GCRS) has published a 100-page white paper that diagnoses a fragmented global regulatory landscape and sets out a working architecture to address it.
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
Prohibition Partners pairs a decade of cannabis market infrastructure with the international network of PPX’s new Managing Director.
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
